ANTH
Anthera Pharmaceuticals, Inc.
ANTH
ANTH
Delisted
ANTH was delisted on the 27th of June, 2018.
35 hedge funds and large institutions have $3.21M invested in Anthera Pharmaceuticals, Inc. in 2017 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 9 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
35
Holding in Top 10
–
Calls
$427K
Puts
–
Top Buyers
| 1 | +$71K | |
| 2 | +$49K | |
| 3 | +$45.7K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$32.8K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$27K |
Top Sellers
| 1 | -$779K | |
| 2 | -$83.6K | |
| 3 | -$70K | |
| 4 |
Goldman Sachs
New York
|
-$69K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$60.8K |